Myocytes have ACE2 on the cell member, acting as a viral gateway and facilitating SARS-CoV-2 entrance into the myocytes, manifesting with different cardiac events.[44] This study adds to the growing evidence linking hyponatremia and SIADH in COVID-19 patients. The gene discussed is ACE2; the disease is COVID-19.